These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8116194)

  • 1. The protective M proteins of the equine group C streptococci.
    Timoney JF; Mukhtar MM
    Vet Microbiol; 1993 Nov; 37(3-4):389-95. PubMed ID: 8116194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and protective immunogenicity of the SzM protein of Streptococcus zooepidemicus NC78 from a clonal outbreak of equine respiratory disease.
    Velineni S; Timoney JF
    Clin Vaccine Immunol; 2013 Aug; 20(8):1181-8. PubMed ID: 23740925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of murine monoclonal antibodies recognising opsonic, mouse-protective, chaining and mucosally relevant epitopes on the M protein of Streptococcus equi subspecies equi.
    Timoney JF; Guan M
    Res Vet Sci; 1996 Jan; 60(1):76-81. PubMed ID: 8745261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the immunogenicity of Streptococcus equi vaccines in foals.
    Srivastava SK; Barnum DA
    Can J Comp Med; 1985 Oct; 49(4):351-6. PubMed ID: 4075235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of pony foals with M-like protein of Streptococcus equi.
    Srivastava SK; Barnum DA
    Am J Vet Res; 1983 Jan; 44(1):41-5. PubMed ID: 6824223
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection against Streptococcus equi infection by monoclonal antibodies against an M-like protein.
    Jean-François MJ; Poskitt DC; Turnbull SJ; Macdonald LM; Yasmeen D
    J Gen Microbiol; 1991 Sep; 137(9):2125-33. PubMed ID: 1721084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affects of N-terminal variation in the SeM protein of Streptococcus equi on antibody and fibrinogen binding.
    Timoney JF; DeNegri R; Sheoran A; Forster N
    Vaccine; 2010 Feb; 28(6):1522-7. PubMed ID: 20005857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of C3 deposition on Streptococcus equi subsp. equi by M protein: a mechanism for survival in equine blood.
    Boschwitz JS; Timoney JF
    Infect Immun; 1994 Aug; 62(8):3515-20. PubMed ID: 8039922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of mucosal and systemic antibody specific for SeMF3 of Streptococcus equi by intranasal vaccination using a sucrose acetate isobutyrate based delivery system.
    Nally JE; Artiushin S; Sheoran AS; Burns PJ; Simon B; Gilley RM; Gibson J; Sullivan S; Timoney JF
    Vaccine; 2000 Oct; 19(4-5):492-7. PubMed ID: 11027813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal nasopharyngeal immune responses of horses to protein antigens of Streptococcus equi.
    Galan JE; Timoney JF
    Infect Immun; 1985 Mar; 47(3):623-8. PubMed ID: 3972443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal mucosal immunogenicity for the horse of a SeM peptide of Streptococcus equi genetically coupled to cholera toxin.
    Sheoran AS; Artiushin S; Timoney JF
    Vaccine; 2002 Feb; 20(11-12):1653-9. PubMed ID: 11858875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field evaluation of a commercial M-protein vaccine against Streptococcus equi infection in foals.
    Hoffman AM; Staempfli HR; Prescott JF; Viel L
    Am J Vet Res; 1991 Apr; 52(4):589-92. PubMed ID: 2053730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic and genetic comparison of Streptococcus equi isolates from the United States and Europe.
    Galán JE; Timoney JF
    J Clin Microbiol; 1988 Jun; 26(6):1142-6. PubMed ID: 3384926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of immunoreactivity to a Streptococcus equi subsp. zooepidemicus M-like protein To confirm an outbreak of poststreptococcal glomerulonephritis, and sequences of M-like proteins from isolates obtained from different host species.
    Nicholson ML; Ferdinand L; Sampson JS; Benin A; Balter S; Pinto SW; Dowell SF; Facklam RR; Carlone GM; Beall B
    J Clin Microbiol; 2000 Nov; 38(11):4126-30. PubMed ID: 11060079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine potential of novel surface exposed and secreted proteins of Streptococcus equi.
    Timoney JF; Qin A; Muthupalani S; Artiushin S
    Vaccine; 2007 Jul; 25(30):5583-90. PubMed ID: 17360081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses.
    Bronze MS; Courtney HS; Dale JB
    J Immunol; 1992 Feb; 148(3):888-93. PubMed ID: 1370521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
    Bessen D; Fischetti VA
    J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the sequences and functions of Streptococcus equi M-like proteins SeM and SzPSe.
    Timoney JF; Artiushin SC; Boschwitz JS
    Infect Immun; 1997 Sep; 65(9):3600-5. PubMed ID: 9284125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of the M protein of Streptococcus equi and cloning and expression of the M protein gene in Escherichia coli.
    Galán JE; Timoney JF
    Infect Immun; 1987 Dec; 55(12):3181-7. PubMed ID: 3316035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci.
    Bessen D; Fischetti VA
    Infect Immun; 1988 Oct; 56(10):2666-72. PubMed ID: 2458320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.